Literature DB >> 4080617

Neurotrophic action of VIP on spinal cord cultures.

D E Brenneman, L E Eiden, R E Siegel.   

Abstract

Vasoactive intestinal peptide-like immunofluorescence was observed in 3-5% of the neurons in 4 week old dissociated cultures from fetal mouse spinal cord and dorsal root ganglion. Radioimmunoassay indicated that VIP was spontaneously released into the culture medium. This release was inhibited by tetrodotoxin (TTX). Previous studies indicated that 50-60% of the spinal cord neurons die between days 7 and 21 in vitro. Blockade of electrical activity with TTX during days 8-15 resulted in a 30% decrease in the number of neurons as compared to control cultures. Addition of VIP (0.1 nM) to TTX-treated cultures prevented neuronal cell death. When VIP alone was added to the cultures, no significant difference in the number of neurons from controls was observed. The possibility that VIP influences cholinergic neurons was tested by measuring choline acetyltransferase (CAT) activity at various periods during development. A 48 hour treatment with 0.1 nM VIP increased CAT activity by 50%. The CAT stimulation was observed only during a period in development when naturally occurring neuronal cell death was taking place. The increases in CAT activity were dose dependent within a range of 10(-12) M to 10(-10) M VIP; however, higher concentrations of VIP attenuated the increases in enzyme activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4080617     DOI: 10.1016/0196-9781(85)90132-9

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  18 in total

1.  A femtomolar-acting neuroprotective peptide.

Authors:  D E Brenneman; I Gozes
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

2.  Protection against developmental deficiencies by a lipophilic VIP analogue.

Authors:  I Gozes; M Bachar; A Bardea; A Davidson; S Rubinraut; M Fridkin
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

3.  VIP-Related protection against lodoacetate toxicity in pheochromocytoma (PC12) cells: a model for ischemic/hypoxic injury.

Authors:  E Sigalov; M Fridkin; D E Brenneman; I Gozes
Journal:  J Mol Neurosci       Date:  2000-12       Impact factor: 3.444

4.  Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway.

Authors:  W K Kim; Y Kan; D Ganea; R P Hart; I Gozes; G M Jonakait
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

Review 5.  Activity-dependent neurotrophic factor (ADNF). An extracellular neuroprotective chaperonin?

Authors:  I Gozes; D E Brenneman
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

6.  Lipopolysaccharide induces cell death in cultured porcine myenteric neurons.

Authors:  Marcin Arciszewski; Stefan Pierzynowski; Eva Ekblad
Journal:  Dig Dis Sci       Date:  2005-09       Impact factor: 3.199

7.  Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain.

Authors:  P Gressens; S Marret; J M Hill; D E Brenneman; I Gozes; M Fridkin; P Evrard
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

Review 8.  VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment.

Authors:  J M Muller; V Lelievre; L Becq-Giraudon; A C Meunier
Journal:  Mol Neurobiol       Date:  1995 Apr-Jun       Impact factor: 5.590

9.  Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent.

Authors:  J M Hill; S K McCune; R J Alvero; G W Glazner; K A Henins; S F Stanziale; J R Keimowitz; D E Brenneman
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

Review 10.  Neuropeptides as growth and differentiation factors in general and VIP in particular.

Authors:  I Gozes; D E Brenneman
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.